Folyóiratcikkek tallózása szerző szerint "Walter, Berger"

A találatok rendezése: Rendezés: Találatok:

  • Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study 
    Hoda, M Alireza; Dong, Yawen; Rózsás, Anita; Klikovits, Thomas; László, Viktória; Bahil, Ghanim; Paul, Stockhammer; Judit, Ozsvar; Marko, Jakopovic; Miroslav, Samarzija; Luka, Brcic; Mátyás, Bendek; Ildikó, Szirtes; Glen, Reid; Michaela, B Kirschner; Steven, C Kao; Isabelle, Opitz; Walter, Weder; Thomas, Frauenfelder; Thi Dan Linh, Nguyen-Kim; Clemens, Aigner; Walter, Klepetko; Nico, van Zandwijk; Walter, Berger; Döme, Balázs; Michael, Grusch; Hegedűs, Balázs (2016)
    INTRODUCTION: The deregulation of activin expression is often observed in various malignancies. Previous studies indicate that activin A plays a protumourigenic role in malignant pleural mesothelioma (MPM). The aim of the ...
  • High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma 
    Hoda, M Alireza; Rózsás, Anita; Lang, Elisabeth; Klikovits, Thomas; Lohinai, Zoltán; Török , Szilvia; Berta, Judit; Mátyás, Bendek; Walter, Berger; Hegedűs, Balázs; Walter, Klepetko; Rényi-Vámos, Ferenc István; Michael, Grusch; Döme, Balázs; Viktória, László (2016)
    Activin A (ActA)/follistatin (FST) signaling has been shown to be deregulated in different tumor types including lung adenocarcinoma (LADC). Here, we report that serum ActA protein levels are significantly elevated in ...
  • Trabectedin is active against malignant pleural mesothelioma cell and xenograft models and synergizes with chemotherapy and bcl-2 inhibition in vitro 
    Hoda, Mir A; Pirker, Christine; Dong, Yawen; Schelch, Karin; Heffeter, Petra; Kushtrim, Kryeziu; Sushilla, van Schoonhoven; Thomas, Klikovits; László, Viktória; Rózsás, Anita; Ozsvár, Judit; Walter, Klepetko; Döme, Balázs; Michael, Grusch; Hegedűs, Balázs; Walter, Berger (2016)
    Malignant pleural mesothelioma (MPM) is characterized by widespread resistance to systemic therapy. Trabectedin is an antineoplastic agent targeting both the malignant cells and the tumor microenvironment which has been ...